Onchocerciasis Clinical Trials

Find Onchocerciasis Clinical Trials Near You

A Community Mapping and Participatory Research Protocol for Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations Through Social and Occupational Networks in Nigeria: MISSION Nigeria

Status: Recruiting
Location: See location...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Neglected Tropical Diseases (NTDs) are among the most common groups of diseases affecting over one billion people globally and are disproportionately concentrated in remote, underserved, and marginalized communities. Efforts toward NTD elimination have largely relied on preventive chemotherapy (PC), large-scale distribution of free, safe, and effective medicines to at-risk populations. One major challenge threatening elimination efforts is the poor participation of mobile and migrant populations (MMPs) in treatment programs. Despite this gap, few studies have explored strategies to improve access among these underserved populations. This study aims to determine the burden of NTDs among MMPs and explore strategies for expanding access to preventive chemotherapy through social and occupational networks using community mapping and participatory action research approaches in Nigeria. This project is a multi-site implementation research study involving 15 communities across three Nigerian states-Taraba, Akwa Ibom, and Ondo-representing pastoralist, fishing, and agrarian settings, respectively. The study comprises four phases. The first two formative phases will assess the baseline burden of NTDs and coverage of preventive chemotherapy interventions using community surveys, parasitological and serological assessments, mapping, and participatory workshops to identify migration patterns, anchor points, and social and occupational networks that could support expansion of PC. The third phase will use participatory approaches to co-construct context-specific strategies for expanding access to preventive chemotherapy among MMPs. In the fourth phase, the co-developed strategies will be implemented and evaluated for impact using established implementation research frameworks and mixed methods approaches. Through this project, investigators will develop and evaluate a novel strategy for expanding access to PC among MMPs. The study will generate evidence on the feasibility, acceptability, reach, and sustainability of the proposed approach and is expected to inform adaptable implementation models for inclusive NTD programming in Nigeria and similar endemic settings.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Healthy Volunteers: t
View:

⁃ Participants will be eligible for inclusion if they:

• Are children aged 5-14 years or adult heads of households residing in households identified as belonging to mobile or migrant populations.

• Reside permanently or semi-permanently within the study communities

• Have missed one or more previous rounds of onchocerciasis and/or lymphatic filariasis MDA.

• Are willing to provide the required biological specimens and participate in interviews, surveys, and participatory workshops or discussions as required by the study protocol.

• Provide informed consent or assent with parental/guardian consent where applicable for minors.

Locations
Other Locations
Nigeria
Recruitment is done at the Household level in selected communities
RECRUITING
Ondo
Contact Information
Primary
Uwem Ekpo, PhD
uwemekpo@aksu.edu.ng
+2348092024306
Time Frame
Start Date: 2026-07-01
Estimated Completion Date: 2027-11-30
Participants
Target number of participants: 5760
Treatments
Other: Mobile and Migrant Populations
Mobile and migrant populations in our context refer to individuals or groups who are frequently absent during mass drug administration (MDA) campaigns due to one or more factors, including conflict and insecurity, environmental pressures, seasonal labor migration, or livelihood-related activities such as trade, pastoralism, fishing, leisure, schooling, and other forms of mobility.
Sponsors
Leads: Uwemedimo Friday Ekpo
Collaborators: Mission To Save The Helpless, Hellen Keller International, Nigerian Federal Ministry of Health, Marian University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.